NLA101 in Adults Receiving High Dose Chemotherapy for AML
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Vincent'S Hospital Sydney
Darlinghurst, New South Wales, Australia
- St. George Hospital
Kogarah, New South Wales, Australia
- Calvary Mater Newcastle
Waratah, New South Wales, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Austin Health
Heidelberg, Victoria, Australia
- Epworth Healthcare
Richmond, Victoria, Australia
- Royal Perth Hospital
Perth, Western Australia, Australia
- Gachon University Gil Medical Center
Incheon, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- the Catholic University of Korea'S Seoul St. Mary'S Hospital
Seoul, South Korea
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Usc Norris Comprehensive Cancer Center
Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Norton Cancer Institute, St. Matthews Campus
Louisville, Kentucky, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Mayo Clinic
Rochester, Minnesota, United States
- University of Nebraska Medical Center - Fred & Pamela Buffett Cancer Center
Omaha, Nebraska, United States
- Westchester Medical Center
Hawthorne, New York, United States
- Icahn School of Medicine at Mount Sinai and Mount Sinai Health System
New York, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Weill Cornell Medical College - Newyork-Presbyterian Hospital
New York, New York, United States
- Stony Brook University
Stony Brook, New York, United States
- Duke University Heath System, Duke Cancer Center
Durham, North Carolina, United States
- Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
- Geisinger Medical Center
Danville, Pennsylvania, United States
- West Penn Hospital
Pittsburgh, Pennsylvania, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
- Swedish Cancer Institute
Seattle, Washington, United States
- University of Wisconsin
Madison, Wisconsin, United States
- Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Jan 2018
- Primary completion
- 18 Mar 2019
- Completion
- 18 Mar 2019
- Last update posted
- 30 Mar 2021
- Registered enrollment
- 146
- Registry id
- NCT03301597
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.